Optimind Pharma Corp. (CSE:OMND)

Optimind Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 19, 2025	Feb 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022
Market Capitalization	1	1	1	0	4	-
Market Cap Growth	-	-6.05%	11.92%	-87.47%	-	-
Enterprise Value	1	1	1	1	4	-
Last Close Price	0.01	0.01	0.01	0.01	0.04	-
PS Ratio	4.25	4.25	4.64	3.99	23.01	-
PB Ratio	-2.76	-2.76	-7.34	-3.80	6.12	-
P/TBV Ratio	-	-	-	-	14.58	-
P/OCF Ratio	33.07	33.07	-	-	-	-
EV/Sales Ratio	4.37	4.47	4.83	8.37	21.79	-
Debt / Equity Ratio	-0.64	-0.64	-1.68	-0.97	0.96	0.04
Net Debt / Equity Ratio	-0.11	-0.11	-0.56	-0.75	0.10	-0.40
Net Debt / EBITDA Ratio	-	-	-	-0.13	-0.07	3.09
Asset Turnover	0.71	0.71	0.54	0.15	0.07	-
Quick Ratio	0.43	0.43	0.55	0.51	1.07	2.04
Current Ratio	0.43	0.43	0.55	0.51	1.07	2.80
Return on Equity (ROE)	-	-	-	-547.28%	-167.32%	-
Return on Assets (ROA)	-15.61%	-15.61%	-57.51%	-59.12%	-21.94%	-
Return on Capital Employed (ROCE)	22.90%	22.90%	269.50%	583.80%	-124.30%	-12.80%
Earnings Yield	-22.87%	-22.87%	-39.31%	-284.95%	-78.65%	-
Buyback Yield / Dilution	7.14%	7.14%	-12.00%	-21.38%	-88.09%	-

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error